TIL

TIL

USD

Instil Bio Inc. Common Stock

$15.160-0.610 (-3.868%)

Reaalajas hind

Healthcare
Biotehnoloogia
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$15.770

Kõrge

$16.343

Madal

$15.150

Maht

0.03M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

102.3M

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

0.13M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $10.8Praegune $15.160Kõrge $42.79

Seotud uudised

Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $125 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Instil Bio with a Buy and maintains $125 price target.

Vaata rohkem
HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $125 Price Target
GlobeNewswire

Instil Bio Announces ImmuneOnco's Presentation of '2510 Monotherapy Data in Patients with 2L+ Squamous NSCLC at the 2025 World Conference on Lung Cancer (WCLC)

ORR of 35% in previously treated squamous NSCLC patients with responses across PD-L1 TPS scores Differentiated structure of ‘2510 potentially results in best-in-class monotherapy activity in 2L+ NSCLC for PD-(L)1xVEGF

Vaata rohkem
Instil Bio Announces ImmuneOnco's Presentation of '2510 Monotherapy Data in Patients with 2L+ Squamous NSCLC at the 2025 World Conference on Lung Cancer (WCLC)
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $125 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Instil Bio with a Buy and maintains $125 price target.

Vaata rohkem
HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $125 Price Target